Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor technology

Richik N Ghosh1, Richard DeBiasio, Christine C Hudson

  • 1Cellomics, Inc., Pittsburgh, PA 15219, USA. rghosh@cellomics.com

Related Concept Videos